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ABSTRACT 
 
Background: The Disabilities of the Arm, Shoulder and Hand (DASH) and Constant-Murley 
scores are commonly used instruments. The DASH is patient reported, and the Constant-
Murley combines a clinician reported and a patient-reported part. For patients with a humeral 
shaft fracture, their validity, reliability, responsiveness, and Minimal Important Change 
(MIC) have not been published. This study evaluated the measurement properties of these 
instruments in patients who sustained a humeral shaft fracture. 
Methods: The DASH and Constant-Murley instruments were completed five times until one 
year after trauma. Pain score, Short Form 36, and EuroQol-5D were completed for 
comparison. Internal consistency was determined by the Cronbach α. Construct and 
longitudinal validity were evaluated by assessing hypotheses about expected Spearman rank 
correlations in scores and change scores, respectively, between patient-reported outcome 
measures (sub)scales. The Smallest Detectable Change (SDC) was calculated. The MIC was 
determined using an anchor-based approach. The presence of floor and ceiling effects was 
determined. 
Results: A total of 140 patients were included. Internal consistency was sufficient for DASH 
(Cronbach α = 0.96), but was insufficient for Constant-Murley (α = 0.61). Construct and 
longitudinal validity were sufficient for both patient-reported outcome measures (>75% of 
correlations hypothesized correctly). The MIC and SDC were 6.7 (95% confidence interval 
5.0-15.8) and 19.0 (standard error of measurement, 6.9), respectively, for DASH and 6.1 
(95% confidence interval, -6.8 to 17.4) and 17.7 (standard error of measurement, 6.4), 
respectively, for Constant-Murley. 
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Conclusions: The DASH and Constant-Murley are valid instruments for evaluating outcome 
in patients with a humeral shaft fracture. Reliability was only shown for the DASH, making 
this the preferred instrument. The observed MIC and SDC values provide a basis for sample 
size calculations for future research. 
 
Level of Evidence: Basic Science Study; Validation of Outcome Instrument 
 
Keywords: Humeral Shaft Fracture; DASH; Constant-Murley; patient reported outcome 
measure; measurement properties; responsiveness; reliability; and validity  
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INTRODUCTION 
 
Patient-reported outcome measures (PROMs) are becoming increasingly important 
instruments to evaluate clinical outcome and functional recovery from the patient’s 
perspective.1 An advantage of generic quality of life PROMs, such as like the Short Form 36 
(SF-36) and EuroQoL-5D (EQ-5D), is that they allow comparison across populations with 
different medical conditions. Region-specific instruments give insight in disabilities, pain, 
and problems caused by a specific disease or condition. Some instruments combine a patient-
reported part with a clinician-reported part. Effects of treatment can be monitored over time 
with all three types of instruments, and they can be used to compare different treatment 
strategies. Instruments should only be used if proven reliable and valid. 
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a region-
specific PROM developed in 1996 by a collaborative effort of researchers of the American 
Academy of Orthopedic Surgeons, and the Institute for Work and Health.2 It was designed to 
describe disability experienced by patients with any musculoskeletal condition of the upper 
extremity and to monitor change in symptoms and upper limb function over time.3 The 
DASH outcome measure has been validated in more than 15 languages in patients with a 
number of upper extremity musculoskeletal disorders, including rheumatoid arthritis and 
shoulder impingement syndrome.2, 4 Normative data have been established for the American 
and Norwegian populations.2, 5 The Dutch version of the DASH (DASH-DLV) has also been 
validated in patients with a range of upper extremity disorders.6 
The Constant-Murley score was developed in 1987 and is currently one of the most-
used scales for shoulder (dys)function.7 The Constant-Murley score evaluates shoulder 
function by including clinician-assessed physical examination findings and patient-reported 
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assessments. It has been validated for different shoulder pathologies8, 9 but is also widely used 
for reporting outcome of patients with a humeral shaft fracture.10-15 
Although the DASH and Constant-Murley scores have been validated for a number of 
upper extremity disorders, including shoulder disorders, the measurement properties in the 
specific population of patients with a humeral shaft fracture are unknown. Also, the Minimal 
Important Change (MIC) for patients with this injury has not been published before. Knowing 
this value is important because it may be used as an input parameter for calculating sample 
sizes for future clinical studies. 
 The aim of this study was therefore to evaluate the measurement properties of the 
DASH and Constant-Murley scores in patients who sustained a humeral shaft fracture by 
comparing them with those of general health-related quality of life instruments subscales 
(i.e., SF-36 and EuroQoL-5D) and pain measured with a visual analog scale (VAS).
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MATERIALS AND METHODS 
 
Data of the first 140 consecutive patients included in a multicenter, prospective cohort study 
comparing operative and nonoperative treatment of adults with a humeral shaft fracture were 
used. This study is registered at the Netherlands Trial Register (NTR3617). The study 
protocol for this trial has been published elsewhere.16 The medical research ethics committees 
of all hospitals approved this study, and all patients provided signed informed consent.  
 
Study population 
Patients aged 18 years or older presenting with a humeral shaft fracture (AO type 12-A or 12-
B) to the Emergency Department of one of 32 participating hospitals in the Netherlands were 
included. Exclusion criteria were pathological, recurrent, or open fractures, concomitant 
injuries affecting treatment and rehabilitation of the affected arm, treatment with an external 
fixator, neurovascular injuries requiring immediate surgery (excluding radial nerve palsy), 
additional traumatic injuries of the affected arm that influenced upper extremity function, 
impaired upper extremity function before to the injury, retained hardware around the affected 
humerus, rheumatoid arthritis, any bone disorder possibly impairing bone healing (excluding 
osteoporosis), problems of ensuring follow-up (e.g., no fixed address or cognitive 
impairment), or insufficient comprehension of the Dutch language.  
 
Questionnaires and follow-up measurement 
Patients were asked to complete the DASH Dutch language version questionnaire (DASH-
DVL),6 the Constant-Murley score 7, the VAS for the level of pain, EQ-5D,17 and SF-3618 at 
two and six weeks and at three, six, and 12 months after initiation of treatment. 
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The DASH questionnaire was developed to describe disability experienced by patients 
with any musculoskeletal condition of the upper extremity and to monitor change in 
symptoms and upper limb function over time.4 The DASH questionnaire consists of 30 items, 
scored 1-5. The DASH score is calculated using the formula: ([sum of all item/number of 
questions answered] - 1) x 25. The overall score ranges from 0 to 100 points. High scores 
represent higher disability. Patients needed to have completed at least 27 of 30 of the 
disability/symptom items of the DASH questionnaire to enable calculation of a total DASH 
score.19 The DASH questionnaire has two optional four-item modules enabling measurement 
of symptoms and upper extremity dysfunction in athletes, performing artists, and other 
workers whose jobs require more advanced physical activity. These optional modules were 
not used because they did not apply to the current study population. 
The Constant-Murley score evaluates shoulder function by including clinician-
assessed physical examination findings and patient-reported assessments.8 The right and left 
shoulder are evaluated independently by two clinician-reported items assessing range of 
motion (ROM) and power and two patient-reported items for pain and activities of daily life 
(ADL). These are summarized in four dimensions (Constant-Murley pain, ADL, ROM, and 
power) to create a Constant-Murley total score of 0 to 100 points (15 for pain, 20 for ADL, 
40 for ROM, and 25 for power), with a higher score representing a better function. The power 
subscale was set to zero in patients who were unable to reach 90° abduction or who reported 
pain during the power measurement. Scores were not normalized to age. Detailed calculations 
of the Constant-Murley (sub)scales are published elsewhere.7 
The VAS is used to measure a variety of continuum outcomes. In this study, it was 
used to measure level of pain. Patients were asked to rate level of pain at each follow-up 
evaluation by putting a mark on a horizontal line, 100 mm in length, with word descriptors at 
each end (‘no pain’ at 0 mm and ‘worst pain imaginable’ at 100 mm).20 
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The SF-36 is a validated health survey with 36 questions that represent eight health 
domains that are combined into a Physical Component Summary (PCS) and a Mental 
Component Summary (MCS). The score ranges from 0 to 100, with higher scores 
representing higher quality of life. The scores are converted and compared with the norms for 
the general population of the United States. The SF-36 is the most widely PROM for 
assessing general health.18, 21 A validated Dutch version was used.22 
The EQ-5D is a standardized instrument for measuring health outcome. It consists of 
two parts: the EQ-5D utility score (US), and the EQ Visual Analog Scale (EQ-VAS). The 
EQ-5D US ranges from 0 to 1 and the EQ-VAS ranges from 0 to 100. For both scores, a 
higher score represents a higher quality of life.23 A validated Dutch version was used.17 
 
Statistical analysis 
Data were analyzed using the Statistical Package for the Social Sciences (SPSS) version 21 or 
higher software (IBM Corp., Armonk, NY, USA). Receiver operating characteristic (ROC) 
and Youden index were analysed using MedCalc 14.10.2 software (MedCalc Software, 
Ostend, Belgium). As the raw data for individual items were analyzed, missing data were not 
imputed. 
The measurement properties of the DASH and Constant-Murley scores were 
determined by comparing them with those of the general health-related quality of life 
instruments subscales on the SF-36 and EQ-5D and pain measured with a VAS. 
Reliability was determined by evaluating internal consistency. The data at six months 
were used because the largest heterogeneity (ranging from substantial limitation to full 
recovery) in scores were expected at that time. At an earlier moment, most patients were 
expected to have substantial functional disability, and at a later time a ceiling effect was 
expected owing to a large proportion of full recovery. Internal consistency is defined as the 
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extent to which items in a (sub)scale are intercorrelated, thus measuring the same concept.24 
The correlation between items on a (sub)scale was evaluated by calculating the Cronbach α 
for every (sub)scale. Internal consistency was considered sufficient if the value for Cronbach 
α was between 0.70 and 0.95, provided that the scale is unidimensional. This analysis 
requires a sample size of 10 per item in the instrument, with a minimum of 100 patients.24  
Construct validity represents the extent to which scores on a specific questionnaire 
relate to other measures in a way that is in agreement with prior theoretically derived 
hypotheses concerning the concepts that are being measured.24 The six-months data were 
used. Continuous data were tested for normality using the Shapiro-Wilk test and by 
inspecting the quantile-quantile plots. Because the continuous variables were not normally 
distributed, Spearman rank correlations of the DASH with the (sub)scales of the Constant-
Murley score, EQ-5D, and SF-36 scores were calculated to assess DASH construct validity. 
Correlation coefficients above 0.6, between 0.6 and 0.3, and less than 0.3 were considered 
high, moderate, and low, respectively.25 A high correlation between the DASH score and 
Constant-Murley total and subscale scores with all other (sub)scales or items measuring 
physical health and functioning (i.e., SF-36 Physical Functioning [PF], SF-36 PCS, EQ-5D 
ADL, and EQ-5D US) was anticipated. In addition, a moderate-to-low correlation was 
expected between the SF-36 MCS and the (sub)scales of all other PROMs. A moderate 
correlation of VAS pain with all other (sub)scales was expected. Finally, we hypothesized 
that the other individual pain measures (i.e., the Constant-Murley pain subscale, the SF-36 
Bodily Pain [BP] subscale, and the EQ-5D pain item) would correlate highly with one 
another. Construct validity was considered sufficient if at least 75% of the results were in 
accordance with predefined hypotheses in a (sub)sample of at least 50 patients.24 
Responsiveness refers to the ability of a questionnaire to detect clinically important 
changes over time.24 This was evaluated by assessing longitudinal validity, which refers to 
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the extent to which change in one measurement instrument relates to corresponding change in 
a reference measure.26 In addition, the effect size (ES) and standardized response mean 
(SRM) were determined as measures of the magnitude of change over time. 
Longitudinal validity was evaluated by testing predefined hypotheses about expected 
correlations between DASH and Constant-Murley change scores and the change scores of the 
EQ-5D and SF-36 (sub)scales. Change scores were calculated as the difference in score from 
the first to the last follow-up of all instruments that were completed (i.e., six weeks to 12 
months). Normality was tested according to the Shapiro-Wilk test and by inspecting the 
quantile-quantile plots. Correlation coefficients above 0.6, between 0.6 and 0.3, and less than 
0.3 were considered high, moderate, and low, respectively.26 Apart from the Constant-Murley 
total score, SF-36 BP, and SF-36 PCS, none of the continuous variables showed a normal 
distribution. Therefore, nonparametric Spearman rank correlations were calculated for all 
variables of interest. A moderate-to-high correlation between the change scores of the DASH 
score, the Constant-Murley total score, and the change scores of all other (sub)scales or items 
measuring physical health and functioning (i.e., SF-36 PF, SF-36 PCS, EQ-5D ADL, and EQ 
US) was anticipated. A moderate-to-high correlation between the individual pain measures 
(i.e., Constant-Murley pain subscale, SF-36 BP subscale, and EQ-5D pain item) was 
expected. Longitudinal validity was considered sufficient if at least 75% of the results were in 
accordance with predefined hypotheses in a (sub)sample of at least 50 patients.24 
The ES was calculated by dividing the mean change in score between two time points 
(i.e., score at 12 months minus the score at six weeks) divided by the standard deviation of 
the first measurement.27 The SRM was calculated by dividing the mean change in score 
between two time points (i.e., score at 12 months minus the score at six weeks) divided by the 
standard deviation of this change.27 These effect estimates were interpreted according to 
Cohen: a value of 0.2 to 0.4 is considered a small, 0.5 to 0.7 a moderate, and ≥ 0.8 a large 
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effect.25 A large ES was expected a priori because patients were expected to have substantial 
functional limitations at six weeks, whereas large improvement was expected at 12 months 
for most patients.  
Floor and ceiling effects are present if more than 15% of the study population rates 
the lowest (floor effect) or highest (ceiling effect) possible score on any PROM (sub)scale.28 
This might limit content validity and responsiveness. In the presence of floor and ceiling 
effects, items might be missing from the upper or lower ends of the scale, reducing content 
validity. Likewise, patients with the highest or lowest scores cannot be distinguished from 
one another, indicating limited reliability.24 Data of all follow-up moments were evaluated 
separately. 
The MIC represents the smallest measurable change in an outcome score that is 
perceived significant by patients. This was calculated using an anchor-based method. Patients 
were asked to complete an ‘anchor question’ or ‘transition item’ at six weeks and at three, 
six, and 12 months evaluating their perception of change in the general condition of the 
affected upper limb. The question was: “How is your affected upper arm at this point, in 
comparison to the previous follow-up moment?” The item scored from 1 “much better” 
through 2 “a little better”, 3 “more or less the same (no change)”, 4 “a little worse” and 5 
“much worse”. The anchor or transition item was considered sufficient if a Spearman rank 
correlation (r) exceeding 0.29 between the anchor and the change score of the PROM could 
be demonstrated.29 The change score (score at last follow-up minus the score at completion of 
the transition item) of patients who selected “a little better” on the transition item was 
considered the MIC.  
The MIC was calculated for the total scores by plotting the ROC curve of the change 
in score for patients who scored “a little better” on the transition item compared with patients 
who scored “more or less the same (no change).” The area under the ROC curve is provided 
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as a measure of discriminatory power. The optimal ROC cutoff point calculated with the 
Youden index reflected the value of the MIC. The Youden index is shown with its 95% 
confidence interval (CI) after bootstrapping (1,000 replicates and 900 random-number seeds).  
The smallest intrapersonal change in score that represents (with P < .05) a “real” 
difference above measurement error is defined by the Smallest Detectable Change (SDC) of a 
measurement instrument.1 This was based on the change scores of patients who answered 
“more or less the same/no change” on the transition item; patients were assumed to be stable 
in the interim period. For the individual patient, the SDC was derived from the standard error 
of measurement (SEM) according to the following formula: SDC = 1.96 x √2 x SEM. SEM 
was calculated as SDchange / √2. Ideally, for evaluative purposes, the SDC should be smaller 
than the MIC24
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RESULTS 
 
Study population 
This study population comprised 140 patients who sustained a humeral shaft fracture; of 
these, 19 patients were lost to follow-up (four after two weeks follow-up, five after six weeks, 
six after three months, and four after six months). In addition, seven patients missed one 
follow-up visit (five missed two weeks, one six weeks, and one six months). The median age 
was 58 years (25th percentile-75th percentile, 41-68) and 63 patients (45.0%) were male. The 
right arm was affected in 65 patients (46.4%), and the dominant arm was affected in 64 
patients (45.7%). 
The changes over time in DASH, Constant-Murley total and subscales, and VAS pain 
of patients with a humeral shaft fracture are shown in Fig. 1. All scores showed a decrease in 
symptoms, disability,y or pain over time, except for the Constant-Murley pain subscale, 
which displayed a similar score at all follow-up assessments. The change in SF-36 PCS, SF-
36 MCS, EQ-5D US, and EQ-5D VAS scores over time is shown in Fig 2. The PROM 
(sub)scales scores measuring physical health and general health (SF-36 PCS and EQ-5D US) 
increased over time, but the mental health-related quality of life and the perception of health-
related quality of life state (SF-36 MCS and EQ-5D VAS) were stable over time.  
 
Reliability 
The Cronbach α value of DASH score (α = 0.96) was sufficient, indicating high correlation 
among the 30 items (Table 1). Cronbach α values of the Constant-Murley ROM subscale 
(α=0.88) also indicated sufficient internal consistency. Internal consistency of the Constant-
Murley total score (α = 0.61) and the Constant-Murley ADL subscale (α = 0.60) was  
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Figure 1 (A) Disabilities of the Arm, Shoulder and Hand (DASH), (B) Constant-Murley 
total, (C) Constant-Murley pain, (D) Constant-Murley Activities of Daily Life (ADL), (E) 
Constant-Murley Range of Motion (ROM), and(F) visual analog scale(VAS) pain scores at 
each follow-up visit in patients with a humeral shaft fracture. The horizontal line in the 
middle of each box indicates the median, the top and bottom borders of the box mark the 75th 
and 25th percentiles, respectively, and the whiskers mark the 90th and 10th percentiles.
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Figure 2 (A) Short Form 36 (SF-36) Physical Component Summary (PCS), (B) SF-36 
Mental Component Summary MCS, (C) EuroQoL-5D (EQ-5D) Utility Score (US), and (D) 
EQ-5D visual analog scale (VAS)  scores at each follow-up visit in patients with a humeral 
shaft fracture. The horizontal line in the middle of each box indicates the median, the top and 
bottom borders of the box mark the 75th and 25th percentiles, respectively, and the whiskers 
mark the 90th and 10th percentiles.
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Table 1 Internal consistency of the instruments in patients with a humeral shaft 
fracture* 
 
Instrument No. No. of items Cronbach α 
DASH (all items) 115 30 0.96 
Constant-Murley (all items) 115 10 0.61† 
 ADL 122 4 0.60 
 ROM 122 4 0.88 
 Pain 122 1 N.D. ‡ 
 Power 115 1 N.D. ‡ 
 
ADL, activities of daily life; DASH, Disabilities of the Arm, Shoulder and Hand; N.D., not 
determined; ROM, range of motion. 
* Data are shown for the six months’ follow-up. The maximum number of patients was 125. 
† Value should be interpreted carefully because the total scale is not unidimensional. 
‡ The Constant-Murley pain and power subscales consist of single items. Internal consistency 
does not apply to a single-item domain.  
 
 
insufficient. No Cronbach α was determined for the Constant-Murley pain and power 
subscales, because internal consistency does not apply to a single-item domain. 
 
Construct validity 
Construct validity is presented in Table 2. The calculated Spearman rank correlations 
confirmed 12 of 14 prior hypothesized correlations (85.7%) between the DASH and 
(sub)scales of the other PROMs, indicating sufficient construct validity. The construct 
validity was sufficient for the Constant-Murley total score, and Constant-Murley power (11 
of 14 [78.6%]) was also sufficient. However, construct validity for the other subscales was 
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not sufficient. A high correlation of the DASH score and the Constant-Murley total score was 
found with the subscales of other PROMs focusing on physical health and functioning (i.e., 
SF-36 PCS, SF-36 PF, and EQ-5D US). The DASH showed a moderate correlation with the 
SF-36 MCS, whereas the Constant-Murley total and subscale scores showed low correlations 
with SF-36 MCS. The moderate correlation between the Constant-Murley pain subscale and 
the VAS pain score was hypothesized correctly, but the moderate correlation with the other 
individual pain measures (i.e., SF-36 BP subscale and EQ-5D pain item) contradicted the 
predefined hypotheses. The moderate correlation between the Constant-Murley ROM 
subscale and EQ-5D ADL scores was also not expected.
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Table 2 Construct validity of the instruments in patients with a humeral shaft fracture* 
Variable DASH  Constant-Murley 
   Total Pain ADL ROM Power 
DASH 1  -0.78 [114] 0.52 [121] -0.71 [121] -0.60 [121] -0.57 [114] 
Constant-Murley 
(total score) 
 
-0.78 [114] 
  
1 
 
-0.52 [115] 
 
0.72 [115] 
 
0.89 [115] 
 
0.82 [115] 
Pain 0.52 [121]  -0.52 [115] 1 -0.45 [122] -0.31 [122] -0.24 [115] 
ADL -0.71 [121]  0.72 [115] -0.45 [122] 1 0.48 [122] 0.45 [115] 
ROM -0.60 [121]  0.89 [115] -0.31 [122] 0.48 [122] 1 0.69 [115] 
Power -0.57 [114]  0.82 [115] -0.24 [115] 0.45 [115] 0.69 [115] 1 
VAS Pain 0.72 [123]  -0.53 [115] 0.57 [122] -0.48 [122] -0.34 [122] -0.40 [115] 
SF-36 PCS -0.79 [121]  0.65 [112] -0.38 [119] 0.55 [119] 0.50 [119] 0.54 [112] 
SF-36 MCS -0.31 [121]  0.14 [112] -0.14 [119] 0.11 [119] 0.03 [119] 0.09 [112] 
PF -0.73 [123]  0.65 [114] -0.27 [121] 0.46 [121] 0.53 [121] 0.59 [114] 
BP -0.65 [123]  0.46 [114] -0.55 [121] 0.40 [121] 0.27 [121] 0.38 [114] 
EQ-5D US -0.67 [123]  0.60 [114] -0.33 [121] 0.43 [121] 0.42 [121] 0.55 [114] 
ADL -0.60 [123]  0.53 [114] -0.30 [121] 0.55 [121] 0.38 [121] 0.35 [114] 
Pain -0.57 [123]  0.44 [114] -0.40 [121] 0.35 [121] 0.24 [121] 0.38 [114] 
VAS -0.53 [123]  0.48 [114] -0.24 [121] 0.31 [121] 0.37 [121] 0.45 [114] 
 
ADL, activities of daily life; BP, bodily pain; DASH, Disabilities of the Arm, Shoulder and Hand; EQ-5D, EuroQoL-5D; MCS, Mental 
Component Summary; PCS, Physical Component Summary; PF, Physical Functioning; ROM, range of motion; SF-36, Short Form-36; VAS, 
Visual Analog Scale; US, utility score. 
* Data are shown for the six months’ follow-up. The maximum number of patients was 125. Construct validity is shown as Spearman rank 
correlation coefficients (r) with brackets showing the number of patients included in the correlation: r  > 0.6 high correlation, r = 0.3 to 0.6 
moderate correlation, and r < 0.3 low correlation. Bold correlations were not hypothesized correctly. 
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Responsiveness 
Longitudinal validity is presented in Table 3. The DASH score demonstrated sufficient 
longitudinal validity, with 11 of 14 change score correlations (78.6%) hypothesized correctly. 
As anticipated, a high correlation was found between the change scores of the DASH, the 
Constant-Murley total, and Constant-Murley ADL subscale scores. The moderate correlation 
between the DASH and the SF-36 PCS and SF-36 PF was not expected. The low correlation 
between the DASH and the Constant-Murley power subscale was also not expected. 
The longitudinal validity of the Constant-Murley total score was sufficient. Of the 14 
hypotheses, (85.7%) 12 were correct. The high correlation with the DASH and Constant-
Murley ADL and ROM subscales was as expected. The moderate correlation with the SF-36 
PCS and PF was not expected. The individual Constant-Murley subscales of pain, ADL, 
ROM, and power showed insufficient longitudinal validity, with 57.1%, 71.4%, 64.3% and 
64.3% correct hypotheses, respectively.  
The SRM and the ES of the DASH and Constant-Murley instruments are reported in 
Table 4. The magnitude of change over time was large for the DASH and Constant-Murley 
total and ADL, ROM, and power subscales (SRM and ES >1.3). The magnitude of change for 
the Constant-Murley pain subscale was medium (SRM -0.58 and ES -0.64).
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Table 3 Longitudinal validity of the instruments in patients with a humeral shaft fracture* 
 DASH  Constant-Murley 
   Total Pain ADL ROM Power 
DASH 1  -0.60 [104] 0.45 [114] -0.64 [114] -0.54 [114] -0.14 [104] 
Constant-Murley 
Total score 
 
-0.60 [104] 
  
1 
 
-0.43 [105] 
 
0.76 [105] 
 
0.90 [105] 
 
0.53 [105] 
Pain 0.45 [114]  -0.43 [105] 1 -0.26 [116] -0.29 [115] -0.12 [105] 
ADL -0.64 [114]  0.76 [105] -0.26 [116] 1 0.70 [115] 0.23 [105] 
ROM -0.54 [114]  0.90 [105] -0.29 [115] 0.70 [115] 1 0.29 [105] 
Power -0.14 [104]  0.53 [105] -0.12 [105] 0.23 [105] 0.29 [105] 1 
VAS Pain 0.55 [118]  -0.46 [105] 0.45 [116] -0.46 [116] -0.33 [115] -0.18 [105] 
SF-36 PCS -0.56 [116]  0.54 [102] -0.40 [112] 0.52 [112] 0.48 [112] 0.24 [102] 
SF-36 MCS -0.20 [116]  0.02 [102] 0.01 [112] 0.01 [112] 0.02 [112] -0.07 [102] 
PF -0.57 [117]  0.34 [103] -0.16 [113] 0.34 [113] 0.40 [113] 0.07 [103] 
BP -0.47 [118]  0.40 [104] -0.36 [115] 0.42 [115] 0.37 [114] 0.12 [104] 
EQ-5D US -0.55 [118]  0.51 [104] -0.25 [115] 0.40 [115] 0.46 [114] 0.09 [104] 
ADL -0.50 [118]  0.44 [104] -0.19 [115] 0.41 [115] 0.34 [114] 0.21 [104] 
Pain -0.41 [118]  0.35 [104] -0.43 [115] 0.34 [115] 0.26 [114] 0.18 [104] 
VAS -0.18 [118]  0.25 [104] -0.23 [115] 0.18 [115] 0.15 [114] 0.15 [104] 
 
ADL, activities of daily life; BP, bodily pain; DASH, Disabilities of the Arm, Shoulder and Hand; EQ-5D, EuroQoL-5D; MCS, Mental 
Component Summary; PCS, Physical Component Summary; PF, Physical Functioning; ROM, range of motion; SF-36, Short Form-36; VAS, 
Visual Analog Scale; US, utility score. 
* Responsiveness is shown as Spearman rank correlation coefficients (r) of change in scores between six weeks and 12 months with the number 
of patients included in the correlation between brackets. The maximum number of patients was 121. Values of r > 0.6 indicate high correlation, r 
= 0.3 to 0.6 indicate moderate correlation, and r < 0.3 indicate low correlation. The bold correlations were not hypothesized correctly.
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Table 4 Responsiveness: standardized response mean and effect size of the instruments in patients with a humeral shaft fracture* 
 
Instrument No. Mean change SDchange SRM SD6 weeks ES 
DASH  118 -27.8 17.1 -1.63 18.0 -1.55 
Constant-Murley 105 34.2 21.4 1.60 20.0 1.71 
 Pain 116 -0.5 0.9 -0.58 0.8 -0.64 
 ADL 116 8.6 4.8 1.78 4.3 2.01 
 ROM 115 17.7 13.0 1.36 13.1 1.35 
 Power 105 6.9 6.3 1.10 4.0 1.75 
 
ADL, activities of daily life; DASH, Disabilities of the Arm, Shoulder and Hand; ES, effect size; ROM, range of motion; SD, standard deviation 
of mean change; SRM, standardized response mean. 
* Change scores were calculated from six weeks to 12 months. The maximum number of patients was 121. 
 
Floor and ceiling effects 
Floor effects were not present in the DASH and Constant-Murley total and ADL and ROM subscale scores at any of the follow-up assessments 
(Fig. 3, A). However, floor effects were present in the Constant-Murley pain subscale at all follow-up assessments.  
A ceiling effect was seen for the DASH score at 12 months  of follow-up, with 31.1% of patients reporting no disability at that 
assessment (Fig. 3, B). For the Constant-Murley ADL and ROM subscale scores, ceiling effects were demonstrated at six and 12 months. 
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Figure 3 (A) Floor and(B) ceiling effects of the instruments at each follow-up visit in 
patients with a humeral shaft fracture. ADL, activities of daily life; BP, bodily pain; DASH, 
Disabilities of the Arm, Shoulder and Hand; EQ-5D, EuroQoL-5D; ROM, range of motion; 
SF-36, Short Form-36; MCS, Mental Component Summary; PCS, Physical Component 
Summary; PF, Physical Functioning; US, utility score; VAS, visual analog scale. 
 
MIC and SDC 
Anchor-based MIC and distribution-based SDC values are given in Table V. Thirty percent 
of transition items were reported as “a little better” and 14.4% as “more or less the same (no 
change).” The transition item displayed a sufficient correlation (i.e., r > 0.3) with the change 
scores of the DASH, Constant-Murley total scores, as well as with the Constant-Murley ADL 
and ROM subscales. Insufficient Spearman rank correlations with the transition item was 
found for the change scores of the Constant-Murley pain subscale (r = 0.21) and power 
subscale (r = -0.18); therefore the MIC for the pain and power subscale could not be 
determined. The MIC value was 6.7 (95% CI, 5.0-15.8) for the DASH score and 6.1 (95% CI 
-6.8 to 17.4) for the Constant-Murley score. The MIC was smaller than the SDC for all total 
and subscale scores. The SDC was 19.0 (SEM, 6.9) for the DASH score and 17.7 (SEM 6.4) 
for the Constant-Murley score. 
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Table 5 Minimal Important Change and Smallest Detectable Change values of the instruments in patients with a humeral shaft fracture 
Instrument Scoring  Anchor-based approach*  Distribution-based approach* 
 range  No. AUC MIC Sensitivity 
(%) 
Specificity 
(%) 
 No. SDchange SEM SDC 
DASH 0-100  150 0.66 (0.58-
0.73) 
6.7 
(5.0-15.8)  
45.3 80.8  73 9.7 6.9 19.0 
Constant-Murley  
(total score) 
0-100  105 0.59 
(0.50-0.68) 
6.1  
(-6.8 to 17.4) 
58.1 61.8  55 9.0 6.4 17.7 
 Pain 0-15  120 0.52 
(0.44-0.59) 
N.D. N.D. N.D.  59 0.6 0.4 1.2 
 ADL 0-20  120 0.59 (0.51-
0.67) 
N.D. N.D. N.D.  58 2.4 1.7 4.7 
 ROM 0-40  120 0.62 (0.54-
0.70) 
N.D. N.D. N.D.  58 5.1 3.6 9.9 
 Power 0-25  105 0.57 
(0.48-0.66) 
N.D. N.D. N.D.  55 4.1 2.9 8.0 
 
ADL, activities of daily life; AUC, area under the curve; DASH, Disabilities of the Arm, Shoulder, and Hand; MIC, minimal important change; 
N.D., not determined; ROM, range of motion; SD, standard deviation of mean change; SDC, smallest detectable change; SEM, standard error of 
measurement. 
* Anchor-based and distribution-based methods for MIC and SDC values, respectively. For the MIC, the area under the receiver operating 
characteristic curve and MIC are shown with  95% confidence intervals between brackets.
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DISCUSSION 
 
Results of the current study show that the DASH and Constant-Murley are valid instruments 
to describe symptoms and disability experienced by patients who sustained a humeral shaft 
fracture over time. The DASH was also found to be reliable. 
The DASH instrument and the Constant-Murley ROM subscale demonstrated 
sufficient internal consistency in this population, as reflected by Cronbach α values of at least 
0.70. The observed value for the DASH was consistent with previously published values, 
which range from 0.91 to 0.98.30, 31  The Cronbach α, however, exceeded 0.95, suggesting 
that some of the items of the DASH questionnaire might be redundant for adequate construct 
measurement in this research setting. The internal consistency of the Constant-Murley total 
score of 0.61 was within the range of 0.60 to 0.75 described previously.8 The value should be 
interpreted carefully because the total instrument is multidimensional. The insufficient 
internal consistency of the Constant-Murley ADL subscale was a novel finding. However, 
because the Cronbach α is dependent on the number of items in a (sub)scale, the inferior 
result might be related to the small number of items (three items) in the Constant-Murley 
ADL subscale.24 
Construct validity of the DASH score was sufficient, with 85.7% of the predicted 
correlations confirmed. More specifically, the DASH displayed high correlations with the 
Constant-Murley total score, the Constant-Murley ADL and ROM subscales, and subscales 
of other PROMs focusing on physical health and functioning. The unexpected low correlation 
between the DASH and the Constant-Murley  power subscale may suggest that not all 
activities asked in the DASH are affected by differences in power of the shoulder. The high 
correlation between the DASH and the EQ-5D has been published in patients with a proximal 
humeral fracture and was of comparable strength.3 To the contrary, the correlations between 
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the DASH and the SF-36 MCS found in this study was much lower than previously 
described.32 The unexpected moderate correlation between the DASH and the SF-36 PCS and 
PF may be because patients more often than expected had functional limitations caused by 
conditions not affecting the upper extremity; these affect the SF-36 but not the DASH. 
Interestingly, only a moderate correlation was found between the DASH and the EQ-5D 
VAS. This suggests that sustaining a humeral shaft fracture does not necessarily affect a 
patient’s general health perception. Cederlund et al. reported a similar finding in patients who 
received treatment for major hand surgery. The patients in their study had the same median 
general health perception as scored by the EQ-5D VAS at three and six months after 
initiation of treatment.33 
According to Cohen’s25 interpretation, the SRM values of the DASH (-1.63), the 
Constant-Murley total score (1.60) and its (sub)scale scores suggested good to excellent 
ability to detect clinical change over time.25 Other studies reported SRM values for the 
DASH in different contexts, with values ranging from -0.48 to -1.64.34, 35 No published SRM 
values for the Constant-Murley score were found. 
In this study, the DASH and Constant-Murley scores displayed sufficient longitudinal 
validity as reflected by 78.6% and 85.7% of correctly hypothesized correlations, respectively. 
Correlations in change scores of the DASH with the SF-36 PCS and SF-36 MCS were 
comparable to a previous study. 36  
The DASH score displayed a ceiling effect at 12 months’ follow-up. Treatment of 
humeral shaft fractures is aimed at full recovery, and achieving this will cause a ceiling effect 
because patients who have a full recovery report no disabilities on PROMs. In this study, 
population full recovery of a substantial portion of the patients was expected one year after 
the start of treatment, and so a ceiling effect was expected. But because of the ceiling effect, 
differences in the group of patients who reported no disabilities at 12 months’ follow-up 
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cannot be distinguished, making it not suitable to, for example, use this time point to compare 
differences of different treatment strategies.  
The anchor-based MIC for the DASH was 6.7 (95% CI,  5.0-15.8), which is a little 
lower than found in previous studies. Previously published MIC values range from seven in 
patients who sustained ulnar nerve decompression to 15 in patients with shoulder 
impingement syndrome.33, 37 Because MIC values are known to be patient and context 
dependent, it is likely that the differences in study populations explain the differences in 
reported MIC values.24 MICfor the Constant-Murley score has not been reported previously.8 
The SDC as found for this instrument in the current study, 17.7 points, is in line with 17 to 23 
points reported previously for shoulder impingement, supraspinatus tears, and  massive 
rotator cuff tears._ENREF_1338 For monitoring changes in individual patients (e.g. in clinical 
practice), the MIC should be larger than the SDC. This is necessary to make a distinction 
between “real’ change and change induced by measurement error. In research, however, the 
MIC is used differently (e.g., to determine percentages of responders)’, and the measurement 
error is much smaller. For all PROM (sub)scales in this study, the anchor-based MIC was 
smaller than the SDC. This suggests that the observed MIC values in this study fall into the 
range that could be due to chance. 
This study has some limitations. Because there was too much time between two 
subsequent follow-up moments, performing an adequate test-retest analysis was not possible. 
Therefore, calculation of the SEM was done with the corresponding change scores of patients 
who answered “no change” on the transition item. This may have resulted in incorrect SEM, 
because the Spearman rank correlations between the transition item and change scores of the 
Constant-Murley pain subscale was insufficient. For the other items, however, the correlation 
was sufficient, so this did not apply to those items. Similarly, this may have hindered correct 
anchor-based MIC and SDC calculations. As a second limitation, the calculations were done 
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using the non-normalized Constant-Murley scores because the sample size did not allow 
stratification by age.
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CONCLUSIONS 
 
This study confirms, for the first time, that the DASH and Constant-Murley scores are valid 
for evaluating outcome over time in patients who sustained a humeral shaft fracture. 
Reliability was confirmed only for the DASH, making this the most suitable instrument. 
Ceiling effects were noted at one-year follow-up, likely owing to increasing numbers of 
patients with full recovery. For the DASH, the MIC was 6.7 (95% CI, 5.0-15.8) and the SDC 
was 19.0 (SEM, 6.9). For the Constant-Murley score, the MIC was 6.1 (95% CI, -6.8 to 17.4) 
and the SDC was 17.7 (SEM, 6.4). The MIC and SDC values enable adequate sample size 
calculations for future research. 
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